These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33539588)

  • 21. Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.
    Lee L; Lewis LD
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S7-S10. PubMed ID: 28921639
    [No Abstract]   [Full Text] [Related]  

  • 22. The Use of Targeted Therapies for Precision Medicine in Oncology.
    White Al-Habeeb N; Kulasingam V; Diamandis EP; Yousef GM; Tsongalis GJ; Vermeulen L; Zhu Z; Kamel-Reid S
    Clin Chem; 2016 Dec; 62(12):1556-1564. PubMed ID: 27679436
    [No Abstract]   [Full Text] [Related]  

  • 23. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision medicine in oncology: what is it exactly and where are we?
    Le Tourneau C; Kamal M; Bièche I
    Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
    [No Abstract]   [Full Text] [Related]  

  • 25. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
    Morgan G; Aftimos P; Awada A
    Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Making precision oncology the standard of care.
    The Lancet Oncology
    Lancet Oncol; 2017 Jul; 18(7):835. PubMed ID: 28677559
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery.
    Bellinger AM; Arteaga CL; Force T; Humphreys BD; Demetri GD; Druker BJ; Moslehi JJ
    Circulation; 2015 Dec; 132(23):2248-58. PubMed ID: 26644247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine.
    Groenland SL; Mathijssen RHJ; Beijnen JH; Huitema ADR; Steeghs N
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1309-1318. PubMed ID: 31175385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision oncology: origins, optimism, and potential.
    Prasad V; Fojo T; Brada M
    Lancet Oncol; 2016 Feb; 17(2):e81-e86. PubMed ID: 26868357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in access.
    Amaral Duarte F; Aguiar Junior PN; Dienstmann R; Ferreira CG
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(9):981-987. PubMed ID: 37750550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted Therapies in Pediatric Oncology.
    Fischer M
    Drug Res (Stuttg); 2018 Nov; 68(S 01):S14. PubMed ID: 30453366
    [No Abstract]   [Full Text] [Related]  

  • 38. Surgical Oncology in the Age of Genomic Medicine.
    Weber TK
    Surg Oncol Clin N Am; 2015 Oct; 24(4):xiii-xv. PubMed ID: 26363545
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue-Agnostic Cancer Therapy Approvals.
    Gouda MA; Subbiah V
    Surg Oncol Clin N Am; 2024 Apr; 33(2):243-264. PubMed ID: 38401908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
    Molloy MP; Engel A
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.